N-glycans on Nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entry.
about
A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusionModes of paramyxovirus fusion: a Henipavirus perspectiveBimolecular complementation of paramyxovirus fusion and hemagglutinin-neuraminidase proteins enhances fusion: implications for the mechanism of fusion triggeringDeterminants of the Bovine Leukemia Virus Envelope Glycoproteins Involved in Infectivity, Replication and PathogenesisMeasles Virus Fusion Protein: Structure, Function and InhibitionUnity in diversity: shared mechanism of entry among paramyxovirusesHenipavirus mediated membrane fusion, virus entry and targeted therapeuticsCo-assembly of viral envelope glycoproteins regulates their polarized sorting in neuronsThe Neutralizing Activity of Anti-Hepatitis C Virus Antibodies Is Modulated by Specific Glycans on the E2 Envelope ProteinStructures and Mechanisms of Viral Membrane Fusion Proteins: Multiple Variations on a Common ThemeStructure and Mutagenesis of the Parainfluenza Virus 5 Hemagglutinin-Neuraminidase Stalk Domain Reveals a Four-Helix Bundle and the Role of the Stalk in Fusion PromotionSequential conformational changes in the morbillivirus attachment protein initiate the membrane fusion processCrystal Structure of the Pre-fusion Nipah Virus Fusion Glycoprotein Reveals a Novel Hexamer-of-Trimers AssemblyProbing the paramyxovirus fusion (F) protein-refolding event from pre- to postfusion by oxidative footprinting.Activation of paramyxovirus membrane fusion and virus entryEndothelial galectin-1 binds to specific glycans on nipah virus fusion protein and inhibits maturation, mobility, and function to block syncytia formation.Structural and mechanistic studies of measles virus illuminate paramyxovirus entry.Antibody evasion by a gammaherpesvirus O-glycan shieldEvidence for henipavirus spillover into human populations in Africa.The secret life of viral entry glycoproteins: moonlighting in immune evasion.The transmembrane domain sequence affects the structure and function of the Newcastle disease virus fusion protein.Triggering of the newcastle disease virus fusion protein by a chimeric attachment protein that binds to Nipah virus receptorsCanine distemper virus envelope protein interactions modulated by hydrophobic residues in the fusion protein globular head.Unraveling a three-step spatiotemporal mechanism of triggering of receptor-induced Nipah virus fusion and cell entry.Timing of galectin-1 exposure differentially modulates Nipah virus entry and syncytium formation in endothelial cells.Timing is everything: Fine-tuned molecular machines orchestrate paramyxovirus entry.Quantitative analysis of Nipah virus proteins released as virus-like particles reveals central role for the matrix protein.Mechanism of fusion triggering by human parainfluenza virus type III: communication between viral glycoproteins during entryHendra and nipah infection: pathology, models and potential therapies.Emerging paramyxoviruses: molecular mechanisms and antiviral strategiesCoordinate deletion of N-glycans from the heptad repeats of the fusion F protein of Newcastle disease virus yields a hyperfusogenic virus with increased replication, virulence, and immunogenicityMutation of a Single Envelope N-Linked Glycosylation Site Enhances the Pathogenicity of Bovine Leukemia Virus.Multiple Novel Functions of Henipavirus O-glycans: The First O-glycan Functions Identified in the Paramyxovirus FamilyParamyxovirus fusion and entry: multiple paths to a common endN-linked glycosylation attenuates H3N2 influenza viruses.The Role of Conserved N-Linked Glycans on Ebola Virus Glycoprotein 2.Molecular determinants of antiviral potency of paramyxovirus entry inhibitors.Incorporation of functional HN-F glycoprotein-containing complexes into newcastle disease virus is dependent on cholesterol and membrane lipid raft integrityFusion activation by a headless parainfluenza virus 5 hemagglutinin-neuraminidase stalk suggests a modular mechanism for triggering.N-Glycans on the Nipah virus attachment glycoprotein modulate fusion and viral entry as they protect against antibody neutralization
P2860
Q21089597-CCAE1C0A-21B8-4169-AC47-14D7B7B34E6EQ24604089-0CEDB04A-41F9-4561-B3CB-F261B7A14C6FQ24645164-29DC2657-FB38-4D48-A214-FA3407C40E4EQ26749621-6ACC074B-0E98-4B86-A713-A98B0C4DDE3EQ26750552-58A6D9AA-9074-4C26-A30B-503F8731E564Q26864825-52886226-9E37-4905-A100-FB2587D80F52Q27002511-CB8C5508-E880-491C-9960-03061F7D5C3BQ27325854-BE1A853C-0107-45AA-B225-1057107E83E3Q27481009-EE635202-382E-4471-B2C6-36407A253CF5Q27487974-76BBDCAD-D308-4CD1-948C-8B23E623AD93Q27674994-4C61B68F-2CC2-4592-B750-57CBD3E3FA6CQ28547034-3F71B180-CDCE-4297-82FE-E703C239B3D1Q28551413-FE2A75E9-57E6-43C6-988A-72A305C07400Q30582350-F095507E-8581-4724-A694-2598F8A0ACE1Q33638769-FDBADC7C-EBDE-48D7-B13A-ADD5F77212FFQ33640112-133F29AD-F4BC-4130-97A3-8530A68602BCQ33926896-4B19A752-74DB-4C55-90DC-FA398089D41DQ34082672-8B591B0B-40F2-4AA6-8362-82D5B05E598AQ34541512-0FB99442-E673-4AB8-B33B-97A12068A1D3Q34733547-A9997A73-D871-4C9C-B573-DC7E22831574Q34742453-16750129-B362-440B-92FB-BA2ECB40EECDQ34978997-DD554136-F5DA-4042-A354-82D60AD44B40Q34991095-2785805D-F266-42CF-8A35-AC5724A26E73Q35053036-3F61FBB9-DC9D-47C5-9C32-585F71B3369CQ35076790-BC4789D7-90B9-4440-91BE-7517E19EEC4BQ35582400-B930E5BB-A87D-4F6D-BDFD-BB192520324CQ35608833-16332591-781B-4341-87CF-1AA59DFC4A1CQ35643883-D9E98866-8FFD-4FA0-94B1-11392087E3B6Q35658146-ECD6D7B1-A35B-4410-8C79-6B165E2417E8Q35658152-59E89D4D-5872-4D59-9D12-4553D8531440Q35826122-F8F20D15-596D-4FEA-A08B-84B1A0F8B8FEQ35913955-7EC21D01-2029-45D8-88D0-4F81A0244567Q35921009-E6AA0BC4-AAA6-4FC2-9079-E2413A5E9A45Q35943669-DF60CCE4-E7DD-427B-AA42-97F1169D8477Q35947697-F3E7335B-1E63-43EC-BC8C-B54B6BF92E13Q36043248-4B4799B8-A109-4F75-81C7-F2BD1B1609BAQ36099124-3CDBF6DC-D3FA-4208-BD3F-8DEB6524AD3CQ36099170-74D4D38C-80C0-4088-ACF6-B8E12F53D6F4Q36300779-C7FA2B52-1935-45A8-B395-8BEA439BA54BQ36363882-551D8F5D-50C3-40C0-87DF-D5E52BBFC10A
P2860
N-glycans on Nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entry.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
N-glycans on Nipah virus fusio ...... mbrane fusion and viral entry.
@en
type
label
N-glycans on Nipah virus fusio ...... mbrane fusion and viral entry.
@en
altLabel
N-glycans on Nipah virus fusio ...... embrane fusion and viral entry
@en
prefLabel
N-glycans on Nipah virus fusio ...... mbrane fusion and viral entry.
@en
P2093
P2860
P50
P1433
P1476
N-glycans on Nipah virus fusio ...... mbrane fusion and viral entry.
@en
P2093
Andrea Bertolotti-Ciarlet
Daniel Y Choi
Ernest L Levroney
Hector C Aguilar
Jennifer A Fulcher
Linda G Baum
Luciana Kohatsu
Mike C Wolf
Oscar A Negrete
Sara T Hashimi
P2860
P304
P356
10.1128/JVI.80.10.4878-4889.2006
P407
P577
2006-05-01T00:00:00Z